TrialJournal of medical genetics2016

Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry.

Alberto Ortiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.